AgelessRx NAD+ Review: Intro Pricing, Three Formats and Evidence

AgelessRx offers a useful choice of NAD+ formats, but the $79 injection headline is an introduction, not the ongoing monthly price. Its research activity is worth examining. It does not make every product claim a proven outcome for the person considering a prescription.

This review concerns agelessrx.com, the Ann Arbor longevity platform. It is a different business from Try Ageless at tryageless.com, which has its own review. Check the domain before comparing prices or looking up a pharmacy: similar names are an easy way to combine two unrelated companies' promises.

The injection headline needs its second line

The injection page advertises $79 for the first month on a three-month plan billed in full, followed by $149 per month. It also offered monthly plans without displaying a complete price ladder in the material we reviewed.¹ We would not describe $79 as a continuing subscription or silently substitute it for the refill rate.

Before ordering, ask for the amount taken from your card today, how that covers the first three months, the next renewal amount and the supply attached to your prescription. We have not inferred an initial quarterly total from an offer that separates an introductory month from subsequent pricing. The actual checkout should settle that question before payment.

That matters if you are exploring a treatment with uncertain benefit. A three-month financial commitment can outlast the point when you and your clinician decide it is not useful. Compare the ordinary renewal price and refund conditions with Willow's NAD+ plans and Enhance MD's four-week billing, then compare the prescribed quantity. A cheaper introductory month does not automatically mean cheaper ongoing care.

Nasal spray and patches are separate purchases

The nasal page listed $125 monthly on subscription and $140 for a one-time purchase.² A separate official patch landing page advertised $160 per kit with two kits billed quarterly.³ A kit price is not a monthly price. We would confirm the number of patches and interval before translating that offer into a budget.

Think about the routine you can manage. A nasal spray avoids needles; an iontophoresis patch is a device-assisted skin application, not an ordinary supplement sticker. An injection requires storage and technique. These distinctions matter to convenience and adherence, but none proves that one route will relieve your fatigue or improve your memory.

If you are unsure which to choose, ask the prescriber to explain why the proposed route fits your situation and how success will be measured. Without an agreed goal, it is easy to keep refilling because something might be helping, even when the symptom that prompted the purchase has not changed.

What the care and cancellation policies say

AgelessRx's FAQ describes licensed-clinician review, with video visits required in some states or requested by the clinician or patient. Approval precedes prescription charging. Subscription shipping is included. Cancellation or a pause should occur before the next refill; the company asks for 48 hours' notice and does not promise a refund once an order is with the pharmacy. It does not accept returns after a prescription leaves the pharmacy.⁴

The useful part is knowing when to act. Put the refill date in your calendar instead of treating “cancel anytime” as a right to reverse an already dispensed order. Ask how a prepaid plan is handled if you stop between shipments, since stopping future renewals and recovering money already paid are different things.

The FAQ says the service operates across the United States while availability depends on treatment and state. That is not a promise that every NAD+ format ships to every state.⁴ Confirm the product you want, your residential address and the dispensing pharmacy. A general national-service claim cannot substitute for those details.

The research is real, but the question is narrower

AgelessRx-affiliated researchers published a 36-patient pilot involving low-dose naltrexone plus NAD+ iontophoresis patches for persistent fatigue after COVID-19. Fatigue and quality-of-life scores improved over twelve weeks, and some participants developed brief skin irritation. Company-employed authors disclosed their relationship.⁵

It is fair to give the company credit for publishing research. It is also necessary to say what the study cannot answer: without a randomized comparison and with two interventions used together, it cannot isolate the patch's contribution. It does not establish that the nasal spray or injection treats ordinary brain fog, and it is not a basis to prescribe this combination to yourself.

The nasal page's customer-benefit statistic comes from a self-reported survey, not a placebo-controlled trial.² A patient survey can describe how respondents felt. Expectations, selection of respondents and other changes in care remain possible explanations. Treat it as feedback from customers rather than a probability that you will get the same result.

For a buyer, the strongest question is not whether the company has ever published a study. It is whether the study tests the product, route, symptom and type of patient relevant to you. Our review directory and NAD+ evidence guide help keep those comparisons separate.

Safety and the final decision

AgelessRx states that its prescription preparations are compounded and not FDA-reviewed or approved for safety, efficacy or quality.¹ FDA's sterile-compounding alert explains why the source and quality of injectable ingredients matter; it does not identify AgelessRx as responsible for the events described.⁶ Ask which pharmacy fills your prescription and whom to contact about a damaged, warm or questionable shipment.

Our verdict: AgelessRx deserves consideration for its range of formats and published research, provided you budget for the follow-on price and keep the evidence in perspective. We would not pick it solely for the $79 headline or a percentage of surveyed customers. Persistent cognitive symptoms still deserve an assessment of their cause, and an experimental purchase should have a clear plan for reviewing benefit and stopping if appropriate.

Based on public product, FAQ, patch-offer and research sources. This is a document-based buyer review; we did not enroll, receive medication or test the service.